article

Issue #4 2016 – Digital edition

Posted: 24 August 2016 | | 2 comments

In this issue: Regulation, Environmental Monitoring, Drug Delivery; Microbiology, Track & race, Spectroscopy, HPLC, Mass Spectrometry, and much more…

European Pharmaceutical Review - Issue 4 2016
  • FOREWORD: EPR health-based exposure limits for cleaning qualification
    David P. Elder, JPAG chair and Consultant
  • REGULATORY INSIGHT: The legal framework applicable to biosimilars in the EU
    Hilary Jones, Bristows LLP
  • ENVIRONMENTAL MONITORING: IN-DEPTH FOCUS
    With articles from R. Vijayakumar, Majmaah University, Tim Sandle, Bio Products Laboratory and Anastasia Petropoulou, University Hospital Bristol’s NHS Foundation Trust
  • DRUG DELIVERY: Approaches in subcutaneous delivery of monoclonal antibodies
    Claus Geiger, Till Bussemer, Tanya Mezhebovsky and Bernardo Perez-Ramirez, Sanofi
  • MICROBIOLOGY SERIES: Current activities of the USP general chapters
    Radhakrishna Tirumalai, PhD, United States Pharmacopeial Convention
  • TRACK AND TRACE
    Including legal analysis from Kathleen M. Sanzo and Jacqueline Berman, Morgan, Lewis & Bockius LLP, and Jacob Gifford Head, Thomas More Chambers
  • SPECTROSCOPY: IN-DEPTH FOCUS
    With contributions from Koen De Smet, Tom Van Den Kerkhof and Anke Prudic, Janssen, and Daniel Markl, Michael T. Ruggiero, and J. Axel Zeitler, University of Cambridge
  • HPLC: Application of LCMS in small-molecule drug development
    Chunang (Christine) Gu, David Russell and Peter Yehl, Genentech
  • MASS SPECTROMETRY: Characterising therapeutic antibodies and ADCs using mass spectrometry
    Ioannis Papayannopoulos, Celldex Therapeutics

The digital version of Issue #4 2016 is restricted to logged-in members. Login or subscribe free to read it.


2 responses to “Issue #4 2016 – Digital edition”

  1. Festo says:

    Good content

Leave a Reply

Your email address will not be published. Required fields are marked *

Send this to a friend